Consistent with facts that NDUFS4 mediated oxidative metabolism acts as a barrier to the response of PD-1 blockade in melanoma (Najjar et al., 2019), and more and more studies convey the concept that tumor cell metabolites epigenetically regulate the immune cell phenotype (Jiang et al., 2020). This evidence concerns the gene PDCD1 and melanoma.